4′-O-Tetrahydropyranyl-doxorubicin in advanced breast cancer: a phase II study
1990; Springer Science+Business Media; Volume: 26; Issue: 4 Linguagem: Inglês
10.1007/bf02897233
ISSN1432-0843
AutoresHellmut Samonigg, Anne-Katrin Kasparek, Herbert Stöger, Marianne Schmid, Bernd Eber, Gerhard Stärk, Viktor Weinrauch, Karl Pfeiffer, M.G. Smola, P. Steindorfer, P. Lechner,
Tópico(s)HER2/EGFR in Cancer Research
Referência(s)